Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-840P is a pseudogene in the human genome corresponding to a non-functional copy of the U6 small nuclear RNA gene[1][4][7]. U6 snRNA is a critical RNA component of the spliceosome, required for pre-mRNA splicing; however, RNU6-840P lacks protein-coding potential and is not known to produce a functional RNA or protein product[1][4]. As a pseudogene, RNU6-840P is considered a genomic relic of the U6 snRNA gene and does not have the established biological activities or therapeutic relevance of the canonical, functional U6 snRNA gene[1][4][7]. There is no evidence supporting a direct role of RNU6-840P in normal biological processes or disease, and it is not considered a druggable or therapeutic target. Clarifications: - This entry refers specifically to a pseudogene, not the functional U6 snRNA or its protein complexes[1][4][7]. - Pseudogenes like RNU6-840P may sometimes have regulatory RNA roles in principle (e.g., as competing endogenous RNAs), but no evidence currently supports such a function for this specific pseudogene[1][4][7][6]. - The pseudogene is not associated with drugs, disease roles, biomarkers, or known safety concerns in therapeutic contexts. Summary: RNU6-840P is a non-coding RNA pseudogene representing a non-functional copy of the U6 small nuclear RNA gene, with no established role as a therapeutic target, biomarker, or disease gene in current biomedical knowledge[1][4][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 840, pseudogene (RNU6-840P).